PRIVATE COMPANIES FOR PHASE-I STUDIES

被引:0
|
作者
LHOSTE, F
机构
[1] Service de Pharmacologie Clinique, Hôpital Necker-Enfants Malades, Paris, 75015, 161, rue de Sèvres
关键词
PHASE-I STUDY; SAFETY; HEALTHY VOLUNTEERS; PRIVATE CLINICAL LABORATORIES;
D O I
10.1111/j.1472-8206.1990.tb00084.x
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
In France, the debate is still open regarding where phase I studies should take place. According to its strict definition, very few phase I studies are performed per year in our country. Because they are usually carried out on healthy volunteers, ethics and safety are intimately mixed in with such studies. Safety in these highly specific investigations is founded on 2 bases, first on the independence of the investigator and secondly on the laboratory environment. The economic independence and total lack of responsibility in this respect on the part of the investigator ensure that all ethical considerations including safety are focused on the personal interest of the volunteer who participates in the study.
引用
收藏
页码:S221 / S223
页数:3
相关论文
共 50 条
  • [31] PHASE-I METABOLISM
    KREMERS, P
    ARCHIVES INTERNATIONALES DE PHARMACODYNAMIE ET DE THERAPIE, 1984, 270 (01): : 174 - 174
  • [32] SINGLE DOSE TOLERANCE STUDIES AT INCREASING DOSES IN PHASE-I
    PATAT, A
    SURJUS, A
    THERAPIE, 1987, 42 (03): : 321 - 321
  • [33] ARE PHASE-I STUDIES WITHOUT DRUG LEVEL DETERMINATION ACCEPTABLE
    MORSELLI, PL
    FUNDAMENTAL & CLINICAL PHARMACOLOGY, 1990, 4 : S125 - S133
  • [34] PHASE-I CLINICAL-STUDIES WITH WR-2721
    KLIGERMAN, MM
    SHAW, MT
    SLAVIK, M
    YUHAS, JM
    CANCER CLINICAL TRIALS, 1980, 3 (03) : 217 - 221
  • [35] PHASE-I AND OTHER DOSE-RANGING STUDIES OF ONDANSETRON
    GRUNBERG, SM
    SEMINARS IN ONCOLOGY, 1992, 19 (04) : 16 - 22
  • [36] PHARMACOKINETICS OF TAUROMUSTINE IN CANCER-PATIENTS - PHASE-I STUDIES
    GUNNARSSON, PO
    VIBEPETERSEN, J
    MACPHERSON, JS
    WARRINGTON, PS
    POLACEK, J
    ELLMAN, M
    HANSEN, HH
    SMYTH, JF
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 1989, 23 (03) : 176 - 180
  • [37] PHARMACOKINETIC STUDIES OF ANTICANCER AGENTS DURING PHASE-I TRIALS
    KOVACH, JS
    INVESTIGATIONAL NEW DRUGS, 1984, 2 (01) : 112 - 112
  • [38] DESIRED AND UNDESIRED EFFECTS OF TEST SUBSTANCES IN PHASE-I STUDIES
    IMHOF, P
    ARZNEIMITTEL-FORSCHUNG/DRUG RESEARCH, 1973, 23 (8A): : 1147 - 1150
  • [39] PHASE-I AND PHOTOTOXICITY STUDIES OF PSEUDOUREA (NSC-56054)
    FREI, E
    LUCE, JK
    LOO, TL
    CANCER CHEMOTHERAPY REPORTS PART 1, 1971, 55 (01): : 91 - &
  • [40] PHASE-I STUDIES WITH CARBOPLATIN AT THE ROYAL-MARSDEN-HOSPITAL
    CALVERT, AH
    HARLAND, SJ
    NEWELL, DR
    SIDDIK, ZH
    HARRAP, KR
    CANCER TREATMENT REVIEWS, 1985, 12 : 51 - 57